Regenerating new heart with stem cells.

PubWeight™: 1.83‹?› | Rank: Top 3%

🔗 View Article (PMC 3533279)

Published in J Clin Invest on January 02, 2013

Authors

Piero Anversa1, Jan Kajstura, Marcello Rota, Annarosa Leri

Author Affiliations

1: Department of Anesthesia and Division of Cardiovascular Medicine, 75 Francis Street, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. panversa@partners.org

Associated clinical trials:

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (SCIPIO) | NCT00474461

Articles citing this

c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature (2014) 3.78

Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol (2013) 2.25

Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19

Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78

Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells. Circulation (2013) 1.61

Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res (2014) 1.59

The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development. PLoS Pathog (2014) 1.41

Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep (2014) 1.20

Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev (2013) 1.08

Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat Commun (2015) 1.07

Cardiac regeneration: current therapies-future concepts. J Thorac Dis (2013) 1.04

Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication (2014) 0.98

Long-Term Outcome of Administration of c-kitPOS Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year. Circ Res (2016) 0.98

Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways. Circ Res (2016) 0.94

Cardiac stem cell niches. Stem Cell Res (2014) 0.91

S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction. J Am Heart Assoc (2015) 0.91

Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res (2015) 0.91

Origin of cardiomyocytes in the adult heart. Circ Res (2015) 0.89

Innate regeneration in the aging heart: healing from within. Mayo Clin Proc (2013) 0.89

Cardiovascular science: opportunities for translating research into improved care. J Clin Invest (2013) 0.88

The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair. Int J Mol Sci (2013) 0.87

HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal (2013) 0.87

Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol (2015) 0.85

Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med (2015) 0.85

Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis. Stem Cells Transl Med (2015) 0.83

Human heart failure: is cell therapy a valid option? Biochem Pharmacol (2013) 0.82

Stem cells: bone-marrow-derived cells and heart failure--the debate goes on. Nat Rev Cardiol (2013) 0.82

The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away. Circ Res (2017) 0.80

Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal (2014) 0.80

New and old technologies for organ replacement. Curr Opin Organ Transplant (2013) 0.79

Characterization of contracting cardiomyocyte colonies in the primary culture of neonatal rat myocardial cells: a model of in vitro cardiomyogenesis. Cell Cycle (2014) 0.79

PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine. Ann Biomed Eng (2013) 0.79

Predicting the future with stem cells. Circulation (2013) 0.79

Pregnancy-induced physiological hypertrophy protects against cardiac ischemia-reperfusion injury. Int J Clin Exp Pathol (2013) 0.78

Chronic heart failure: opportunities for a bridge between China and the United States. Circ Res (2013) 0.78

CENP-A is essential for cardiac progenitor cell proliferation. Cell Cycle (2013) 0.78

AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling. F1000Prime Rep (2013) 0.77

Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart. F1000Prime Rep (2014) 0.77

Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation. Tissue Eng Part B Rev (2015) 0.77

Developmental origin and lineage plasticity of endogenous cardiac stem cells. Development (2016) 0.77

Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease. Stem Cells Int (2015) 0.77

Pharmacological Strategies to Retard Cardiovascular Aging. Circ Res (2016) 0.76

Use of stem cells in heart failure treatment: where we stand and where we are going. Methodist Debakey Cardiovasc J (2013) 0.76

Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells. Arterioscler Thromb Vasc Biol (2016) 0.76

Cell therapy in Brazil: time for reflection. Rev Bras Hematol Hemoter (2013) 0.75

Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction. J Am Heart Assoc (2014) 0.75

Nanomaterials for Cardiac Myocyte Tissue Engineering. Nanomaterials (Basel) (2016) 0.75

Widespread Intracoronary Cardiopoietic Cell Infusion: Treating at the Time of Myocardial Reperfusion to Prevent Rather Than Reverse Established Left Ventricular Dysfunction Moves Us Closer to Practical Clinical Translation. Circ Res (2016) 0.75

Brain derived neurotrophic factor contributes to the cardiogenic potential of adult resident progenitor cells in failing murine heart. PLoS One (2015) 0.75

A Novel Class of Human Cardiac Stem Cells. Cardiol Rev (2015) 0.75

Concise Review: Stem Cell Microenvironment on a Chip: Current Technologies for Tissue Engineering and Stem Cell Biology. Stem Cells Transl Med (2015) 0.75

Can stem cells really regenerate the human heart? Use your noggin, dickkopf! Lessons from developmental biology. Cardiovasc J Afr (2013) 0.75

Hypoxic Preconditioning Inhibits Hypoxia-induced Apoptosis of Cardiac Progenitor Cells via the PI3K/Akt-DNMT1-p53 Pathway. Sci Rep (2016) 0.75

Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury. Cell Death Dis (2016) 0.75

A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors. Transplant Direct (2017) 0.75

SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions. PLoS One (2017) 0.75

Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease. Exp Ther Med (2017) 0.75

Articles cited by this

(truncated to the top 100)

Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24

Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09

Evidence for cardiomyocyte renewal in humans. Science (2009) 14.17

Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45

Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87

Chimerism of the transplanted heart. N Engl J Med (2002) 8.69

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med (2007) 8.06

Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87

Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med (2006) 7.28

Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19

Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell (2009) 6.77

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68

Apoptosis in the failing human heart. N Engl J Med (1997) 6.35

Plasticity of the differentiated state. Science (1985) 6.19

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation (2006) 5.99

Heart regeneration. Nature (2011) 5.91

A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res (2010) 5.47

In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell (2007) 5.32

Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68

Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58

Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res (2007) 4.53

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA (2011) 4.52

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest (2006) 4.51

Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13

Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med (2007) 3.98

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93

p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 3.88

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61

Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell (2011) 3.56

Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell (2011) 3.49

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39

Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science (2005) 3.32

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA (2012) 3.30

Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30

Lack of a fusion requirement for development of bone marrow-derived epithelia. Science (2004) 3.14

Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06

Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95

Cardiac regeneration: repopulating the heart. Annu Rev Physiol (2006) 2.92

Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79

Myocyte turnover in the aging human heart. Circ Res (2010) 2.77

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res (2011) 2.76

Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71

Lineage tracing. Cell (2012) 2.67

Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60

Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A (1998) 2.60

IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res (2008) 2.53

Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51

Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45

Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur Heart J (2002) 2.41

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31

Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23

Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res (2007) 2.08

Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res (2011) 2.02

Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98

A family business: stem cell progeny join the niche to regulate homeostasis. Nat Rev Mol Cell Biol (2012) 1.91

Transdifferentiation and metaplasia--switching cell types. Curr Opin Genet Dev (2001) 1.81

Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells (2008) 1.80

Stem cells: lost in translation. Nature (2004) 1.79

Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res (2011) 1.77

Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell (2011) 1.72

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest (2009) 1.69

Cardiac regeneration. J Am Coll Cardiol (2006) 1.67

The haematopoietic stem cell niche at a glance. J Cell Sci (2011) 1.63

Effects of age and heart failure on human cardiac stem cell function. Am J Pathol (2011) 1.57

How to interpret elevated cardiac troponin levels. Circulation (2011) 1.48

Cardiac progenitor cell cycling stimulated by pim-1 kinase. Circ Res (2010) 1.46

Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42

Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res (2012) 1.37

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart (2009) 1.36

Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium. Circ Res (2011) 1.36

Cardiomyocyte renewal. N Engl J Med (2009) 1.33

Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ Res (2009) 1.32

Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res (2008) 1.28

Regeneration of the heart. EMBO Mol Med (2011) 1.27

Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng (2011) 1.26

Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol (2004) 1.26

Ferreting out stem cells from their niches. Nat Cell Biol (2011) 1.24

Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol (2005) 1.22

Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol (2005) 1.21

CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells (2008) 1.20

Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. J Nucl Med (2002) 1.19

Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res (2011) 1.13

Acute renal infarction. J R Soc Med (2005) 1.12

Multifactorial aetiology of hepatic infarction: a case report with literature review. Eur J Gastroenterol Hepatol (2004) 1.09

Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis (2008) 1.08

Acute mesenteric ischemia. Curr Gastroenterol Rep (2008) 1.04

Human cardiac stem cells: the heart of a truth. Circulation (2009) 1.02

Tissue-specific adult stem cells in the human lung. Nat Med (2011) 0.97

Development biology. Turnover after the fallout. Science (2009) 0.92

Rewind to recover: dedifferentiation after cardiac injury. Cell Stem Cell (2011) 0.88

Postnatal development of the M-band in rat cardiac myofibrils. Circ Res (1981) 0.86

CD34+, kit+, rhodamine123(low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia (1998) 0.86

Morphometric and autoradiographic study of developing ventricular and atrial myocardium in fetal rats. Lab Invest (1975) 0.86

Articles by these authors

Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09

Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45

Chimerism of the transplanted heart. N Engl J Med (2002) 8.69

Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76

Evidence for human lung stem cells. N Engl J Med (2011) 5.67

Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13

Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64

Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39

Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30

Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07

Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06

Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95

Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83

Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79

Myocyte turnover in the aging human heart. Circ Res (2010) 2.77

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res (2011) 2.76

Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71

Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60

Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation (2006) 2.56

Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51

Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45

Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med (2007) 2.39

Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 2.38

Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res (2007) 2.38

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36

Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res (2006) 2.34

Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res (2005) 2.32

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31

Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28

Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res (2003) 2.26

Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23

Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.22

Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19

Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16

Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res (2002) 2.11

Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res (2013) 2.06

Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05

Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98

Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res (2006) 1.98

Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge. Circ Res (2008) 1.97

Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res (2011) 1.77